Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

SAGE holding history

Sage Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SAGE overviewAll 13F holders of SAGEFull Q2 2026 holdings

Shares (Q3 2025)
0
Sold out in Q3 2025
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of SAGE by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20250$00.0%−1,917,284−100.0%Sold outHolders
Q2 20251,917,284$17.5M<0.1%−170,159−8.2%ReducedHolders
Q1 20252,087,443$16.6M<0.1%+1,367,338+189.9%AddedHolders
Q4 2024720,105$3.91M<0.1%+73,073+11.3%AddedHolders
Q3 2024647,032$4.67M<0.1%+322,761+99.5%AddedHolders
Q2 2024324,271$3.52M<0.1%+164,933+103.5%AddedHolders
Q1 2024159,338$2.99M<0.1%−95,329−37.4%ReducedHolders
Q4 2023254,667$5.52M<0.1%+52,465+25.9%AddedHolders
Q3 2023202,202$4.16M<0.1%−249,070−55.2%ReducedHolders
Q2 2023451,272$21.2M<0.1%+3,037+0.7%AddedHolders
Q1 2023448,235$18.8M<0.1%−141,214−24.0%ReducedHolders
Q4 2022589,449$22.5M<0.1%−112,035−16.0%ReducedHolders
Q3 2022701,484$27.5M<0.1%−59,201−7.8%ReducedHolders
Q2 2022760,685$24.6M<0.1%−165,851−17.9%ReducedHolders
Q1 2022926,536$30.7M<0.1%−67,733−6.8%ReducedHolders
Q4 2021994,269$42.3M0.1%−262,022−20.9%ReducedHolders
Q3 20211,256,291$55.7M0.1%−60,852−4.6%ReducedHolders
Q2 20211,317,143$74.8M0.1%−554,732−29.6%ReducedHolders
Q1 20211,871,875$140.1M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.